semaglutide trial weight loss STEP 1 : Treatment Effect in People with Obesity – My Endo Consult Effect of Continued Weekly Subcutaneous
Description
Independent editorial review not affiliated with the brand
Among those without CVD, estimated 10-year CVD risks were 10.15% before and 8.34% after semaglutide treatment reflecting a 1.81% absolute (and 17.8% relative) risk reduction translating to 1.50 million preventable CVD events over 10 years
Always follow your pharmacy's specific instructions and consult your provider about stability timelines
In addition, it may contain information that differs from that shown here
PlexusDx delivers compounded semaglutide from licensed pharmacies to all 50 states without insurance
